You are here

Article Text

Article menu
Download PDFPDF
Case report
High-dose quetiapine and therapeutic monitoring
  1. Hervé Javelot1,
  2. Francis Rangoni2,
  3. Luisa Weiner3,
  4. Bruno Michel4
  1. 1 Service de Pharmacie Clinique, Etablissement Public de Santé Alsace Nord, Brumath, France
  2. 2 Pôle G07, Etablissement Public de Santé Alsace Nord, Brumath, France
  3. 3 Psychiatry II, Civil Hospital, CHU Strasbourg, Strasbourg, France
  4. 4 Service de Pharmacie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
  1. Correspondence to Dr Hervé Javelot, Service Pharmacie, Etablissement Public de Santé Alsace Nord, Brumath 67170, France; herve.javelot{at}ch-epsan.fr

Abstract

Quetiapine is an atypical antipsychotic with a good safety profile permitting its administration beyond the maximum dose of 800 mg/day. We report the case of a patient with a resistant schizophrenia treated with high doses of quetiapine (up to 2000 mg/day) combined with drug monitoring and with favourable therapeutic response and tolerance.

  • psychiatry
  • therapeutic drug monitoring
  • antipsychotics
  • quetiapine
  • resistant schizophrenia

https://doi.org/10.1136/ejhpharm-2018-001605

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text